Suchergebnisse - "Hoshida, Yujin"

PubPharm (382)

81

MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma

enthalten in: European radiology | 2020

von Hectors, S. | Lewis, S. | Besa, C. | +13

82

Restricted immunological and cellular pathways are shared by murine models of chronic alcohol consumption

enthalten in: Scientific reports | 2020

von Vogle, A. | Qian, T. | Zhu, S. | +8

83

Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancer

enthalten in: Heliyon | 2020

von Ha, K. | Fujita, M. | Karlić, R. | +10

84

A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor

sonderdruck aus: Nature communications | 2020

von Eller, C. | Heydmann, L. | Colpitts, C. | +20

85

Brazilian cohort and genes encoding for drug-metabolizing enzymes and drug transporters

enthalten in: Pharmacogenomics | 2020

von Kim, V. | Wal, T. | Nishi, M. | +4

86

Omics‐derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases

enthalten in: Hepatology Research | 2020

von Fujiwara, N. | Qian, T. | Koneru, B. | +1

87

Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis

enthalten in: Hepatology | 2020

von Rich, N. | John, B. | Parikh, N. | +18

88

Gene signature‐MELD score and alcohol relapse determine long‐term prognosis of patients with severe alcoholic hepatitis

enthalten in: Liver International | 2020

von Deltenre, P. | Trépo, E. | Fujiwara, N. | +7

89

MS.liverK: an R package for transcriptome-based computation of molecular subtypes and functional signatures in liver cancer

enthalten in: bioRxiv.org | 2019

von Petitprez, F. | Meunier, L. | Letouzé, E. | +8

90

Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular Carcinoma

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Fujiwara, N. | Singal, A. | Hoshida, Y.

CommentOn: JAMA Oncol. 2018 Dec 1;4(12):1683-1690. - PMID 30286235